ETOPOSIDE IN LEUKEMIA, LYMPHOMA AND BONE-MARROW TRANSPLANTATION

被引：39
作者：
STADTMAUER, EA
CASSILETH, PA
GALE, RP
机构：
[1] UNIV PENN,SCH MED,HEMATOL ONCOL SECT,PHILADELPHIA,PA 19104
[2] UNIV CALIF LOS ANGELES,SCH MED,DEPT MED,DIV HEMATOL & ONCOL,LOS ANGELES,CA 90024
来源：
LEUKEMIA RESEARCH | 1989年 / 13卷 / 08期
关键词：
D O I：
10.1016/0145-2126(89)90052-0
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：639 / 650
页数：12
相关论文
共 108 条
[1]  
ABRAMS RA, 1986, CANCER TREAT REP, V70, P535
[2]   ETOPOSIDE (VP-16) WITH PREDNISONE AND VINCRISTINE FOR THE TREATMENT OF REFRACTORY ACUTE LYMPHOBLASTIC-LEUKEMIA [J].
ABROMOWITCH, M ;
BOWMAN, WP ;
OCHS, J ;
RIVERA, G .
JOURNAL OF CLINICAL ONCOLOGY, 1985, 3 (06) :789-792
[3]  
AHMED T, 1987, BLOOD, V70, pA1010
[4]   A PHASE-I TRIAL OF CONTINUOUS INFUSION VP16-213 (ETOPOSIDE) [J].
AISNER, J ;
VANECHO, DA ;
WHITACRE, M ;
WIERNIK, PH .
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1982, 7 (2-3) :157-160
[5]   ANALYSIS OF 4'-DEMETHYLEPIPODOPHYLLOTOXIN-9-(4,6-0-ETHYLIDENE-BETA-D-GLUCOPYRANOSIDE) BY HIGH-PRESSURE LIQUID-CHROMATOGRAPHY [J].
ALLEN, LM .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1980, 69 (12) :1440-1441
[6]   ETOPOSIDE PHARMACOKINETICS IN PATIENTS WITH NORMAL AND ABNORMAL ORGAN FUNCTION [J].
ARBUCK, SG ;
DOUGLASS, HO ;
CROM, WR ;
GOODWIN, P ;
SILK, Y ;
COOPER, C ;
EVANS, WE .
JOURNAL OF CLINICAL ONCOLOGY, 1986, 4 (11) :1690-1695
[7]  
ARLIN ZA, 1985, CANCER TREAT REP, V3, P203
[8]  
ARNOLD AM, 1979, CANCER CHEMOTH PHARM, V3, P71
[9]  
BANDINI G, 1987, HAEMATOLOGICA, V72, P431
[10]   ACTIVITY OF THE EPIPODOPHYLLOTOXIN VP-16 IN THE TREATMENT OF COMBINATION CHEMOTHERAPY-RESISTANT NON-HODGKIN LYMPHOMA [J].
BENDER, RA ;
ANDERSON, T ;
FISHER, RI ;
YOUNG, RC .
AMERICAN JOURNAL OF HEMATOLOGY, 1978, 5 (03) :203-209
12345678910